Market Closed -
Japan Exchange
02:00:00 2024-04-30 am EDT
5-day change
1st Jan Change
534
JPY
+1.71%
+2.10%
+6.16%
JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 2023 and Full Year Ending March 2024
May 12, 2023 at 02:00 am EDT
JMS Co.,Ltd. provided consolidated earnings guidance for the six months ending September 2023 and full year ending March 2024. For the six months, the company expects net sales of ¥32,400 million, operating profit of ¥350 million, profit attributable to owners of parent of ¥300 million and basic earnings per share of ¥12.27.
JMS Co.,Ltd. Announces Dividend for the Second Quarter ended September 2023 Payable on December 8, 2023; Provides Guidance for the Year End for the Year March 31, 2024
Nov. 07
CI
JMS Co.,Ltd. Provides Earnings Guidance for the Year Ending March 31, 2024
Nov. 07
CI
JMS Co.,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
23-05-12
CI
JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 2023 and Full Year Ending March 2024
23-05-12
CI
JMS Co.,Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 28, 2023; Provides Dividend Guidance for the Second Quarter End and Fiscal Year Ending March 31, 2024
23-05-12
CI
JMS Co.,Ltd. Provides Year-End Dividend Guidance for the Year Ending March 31, 2023
23-02-07
CI
JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023
23-02-07
CI
JMS Co.,Ltd.(TSE:7702) dropped from S&P Global BMI Index
22-09-19
CI
JMS Co.,Ltd. agreed to acquire myBeat Home ECG business of Union Tool Co. from Union Tool Co..
22-06-29
CI
Fresenius Medical Care Partners with JMS Co. Ltd. to Advance Home Dialysis Treatment in Japan
21-09-17
CI
JMS Co.,Ltd. agreed to acquire blood purification business from Japan Lifeline Co., Ltd..
21-02-25
CI
JMS Co.,Ltd.(TSE:7702) added to S&P Global BMI Index
20-09-21
CI
Jms Co.,Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2019; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020
20-02-05
CI
JMS Co.,Ltd. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020; Announces Dividend for the Second Quarter Ended September 30, 2019 , Payable on December 10, 2019; Provides Year-End Dividend Guidance for the Year Ending March 31, 2020
19-11-10
CI
Jms Co.,Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Earnings Guidance for the Half Year and Full Year for the Fiscal Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2020
19-08-06
CI
JMS Co.,Ltd. Announces Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Earnings Guidance for the Six Months Ending September 30, 2018 and Full Year Ending March 31, 2019; Announces Dividend for the Year Ended March 31, 2018, Payable on June 22, 2018; Provides Dividend Guidance for the Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2019
18-05-17
CI
JMS Co.,Ltd, Thippayabadin Company Limited, and B&J Logistic Co., Ltd Establishes Joint Venture Company in Thailand
18-03-06
CI
JMS Co.,Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2018
18-02-07
CI
Jms Co.,Ltd. Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended September 30, 2017; Announces Consolidated Earnings Guidance for the Year Ending March 31, 2018; Declares Dividend for the Second Quarter Ended September 30, 2017, Payable on December 8, 2017; Provides Year-End Dividend Guidance for the Year Ending March 31, 2018
17-11-08
CI
JMS Co.,Ltd. announces an Equity Buyback for 197 shares.
17-10-18
CI
JMS Co.,Ltd.'s Equity Buyback announced on October 18, 2017 has expired.
17-10-17
CI
JMS Co.,Ltd. authorizes a Buyback Plan.
17-10-17
CI
JMS Co., Ltd. Reports Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Earnings Guidance for the Six Months Ending September 30, 2017 and Year Ending March 31, 2018
17-05-11
CI
JMS Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended Dec. 31, 2016; Reaffirms Earnings Guidance for the Fiscal Year Ending March 31, 2017
17-02-09
CI
JMS Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2017
16-11-10
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
JMS CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The Company operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The Company is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Companyâs main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The Company is also involved in the provision of maintenance service and other related services.
More about the company
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
JMS CO.,LTD. 
